Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

59:14
 
Share
 

Manage episode 480729260 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Featuring perspectives from Dr Jennifer R Brown and Prof Paolo Ghia, including the following topics:

  • Introduction: The Chronic Lymphocytic Leukemia (CLL) Experience — 2000 to 2025 (0:00)
  • Current Therapy Options with Covalent Bruton Tyrosine Kinase (BTK) Inhibitors (9:42)
  • Role of Venetoclax in the Treatment of CLL (26:52)
  • AMPLIFY Trial and Other Novel BTK Inhibitor and Bcl-2 Inhibitor Combination Strategies (32:29)
  • Noncovalent BTK Inhibitor Pirtobrutinib (46:47)
  • CAR T-Cell Therapy; Novel Agents (56:12)

CME information and select publications

  continue reading

1521 episodes

Artwork
iconShare
 
Manage episode 480729260 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Featuring perspectives from Dr Jennifer R Brown and Prof Paolo Ghia, including the following topics:

  • Introduction: The Chronic Lymphocytic Leukemia (CLL) Experience — 2000 to 2025 (0:00)
  • Current Therapy Options with Covalent Bruton Tyrosine Kinase (BTK) Inhibitors (9:42)
  • Role of Venetoclax in the Treatment of CLL (26:52)
  • AMPLIFY Trial and Other Novel BTK Inhibitor and Bcl-2 Inhibitor Combination Strategies (32:29)
  • Noncovalent BTK Inhibitor Pirtobrutinib (46:47)
  • CAR T-Cell Therapy; Novel Agents (56:12)

CME information and select publications

  continue reading

1521 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play